CAC
CLLS

Certified Advisory Corp’s Cellectis CLLS Stock Holding History

Certified Advisory Corp’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-600
Closed -$17K – 771
2018
Q2 		$17K Hold
600
– – 0.01% 456
2018
Q1 		$18K Buy
+600
New +$19K 0.01% 428

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Certified Advisory Corp's CLLS Position: Q3 2018 in Review

Certified Advisory Corp sold out of Cellectis (CLLS) in Q3 2018, closing a stake of 600 shares — an estimated $17K sold.

Certified Advisory Corp first reported a position in CLLS in Q1 2018 and held it in 2 quarters. The position peaked at $18K in Q1 2018. 81 funds tracked by Wall St. Rank hold CLLS as of Q3 2018.

  • Certified Advisory Corp reported no remaining Cellectis position as of Q3 2018 after selling out during the quarter.
  • Certified Advisory Corp sold 600 Cellectis shares in Q3 2018, an estimated $17K.
  • Certified Advisory Corp first reported a position in Cellectis in Q1 2018 and held it in 2 quarters.
  • Certified Advisory Corp's Cellectis position peaked at $18K in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q3 2018.

Based on Certified Advisory Corp's 13F filing for Q3 2018, filed 13 Nov 2018.